APA (7th ed.) Citation

Sullivan, K. M., Farraye, F. A., Winthrop, K. L., Willer, D. O., Vink, P., & Tavares-Da-Silva, F. (2023). Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions. Vaccine, 41(1), 36. https://doi.org/10.1016/j.vaccine.2022.10.063

Chicago Style (17th ed.) Citation

Sullivan, Keith M., Francis A. Farraye, Kevin L. Winthrop, David O. Willer, Peter Vink, and Fernanda Tavares-Da-Silva. "Safety and Efficacy of Recombinant and Live Herpes Zoster Vaccines for Prevention in At-risk Adults with Chronic Diseases and Immunocompromising Conditions." Vaccine 41, no. 1 (2023): 36. https://doi.org/10.1016/j.vaccine.2022.10.063.

MLA (9th ed.) Citation

Sullivan, Keith M., et al. "Safety and Efficacy of Recombinant and Live Herpes Zoster Vaccines for Prevention in At-risk Adults with Chronic Diseases and Immunocompromising Conditions." Vaccine, vol. 41, no. 1, 2023, p. 36, https://doi.org/10.1016/j.vaccine.2022.10.063.